Search tips
Search criteria 


Logo of brheartjLink to Publisher's site
Br Heart J. 1959 July; 21(3): 369–380.
PMCID: PMC1017593


Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (3.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • AULD WH, WATSON H. Fibro-elastosis of the heart in adolescence. Br Heart J. 1957 Apr;19(2):186–192. [PMC free article] [PubMed]
  • BIORCK G, AXEN O, THORSON A. Unusual cyanosis in a boy with congenital pulmonary stenosis and tricuspid insufficiency. Fatal outcome after angiocardiography. Am Heart J. 1952 Jul;44(1):143–148. [PubMed]
  • CORREALE P. Effetti della somministrazione cronica di 5-idrossitriptamina sulla pressione sistematica nel ratto. Boll Soc Ital Biol Sper. 1953 Aug;29(8):1594–1596. [PubMed]
  • DAVIES JN, BALL JD. The pathology of endomyocardial fibrosis in Uganda. Br Heart J. 1955 Jul;17(3):337–359. [PMC free article] [PubMed]
  • DUNCAN D, GARVEN JD, GIBBONS JL. Argentaffin carcinoma of ileum with raised serum 5-hydroxytryptamine; report of a case. Br Med J. 1955 Dec 31;2(4956):1586–1589. [PMC free article] [PubMed]
  • ERSPAMER V. Pharmacology of indole-alkylamines. Pharmacol Rev. 1954 Dec;6(4):425–487. [PubMed]
  • GOBLE AJ, HAY DR, SANDLER M. 5-Hydroxytryptamine metabolism in acquired heart-disease associated with argentaffin carcinoma. Lancet. 1955 Nov 12;269(6898):1016–1017. [PubMed]
  • GOBLE AJ, HAY DR, HUDSON R, SANDLER M. Acquired heart disease with argentaffin carcinoma. Br Heart J. 1956 Oct;18(4):544–552. [PMC free article] [PubMed]
  • GOWING NFC. Congenital fibro-elastosis of the endocardium. J Pathol Bacteriol. 1953 Jan;65(1):13–28. [PubMed]
  • HANSON A, SERIN F. Determination of 5-hydroxy-indole-acetic acid in urine; and its excretion in patients with malignant carcinoids. Lancet. 1955 Dec 31;269(6905):1359–1361. [PubMed]
  • HEDINGER C, GLOOR R. Metastasierende Dünndarmkarzinoide, Tricuspidalklappenveränderungen und Pulmonalstenose, ein neues Syndrom. Schweiz Med Wochenschr. 1954 Aug 14;84(33):942–946. [PubMed]
  • ISLER P, HEDINGER C. Metastasierendes Dünndarmcarcinoid mit schweren, vorwiegend das rechte Herz betreffenden Klappen-fehlern und Pulmonalstenose; ein eigenartiger Symptomenkomplex? Schweiz Med Wochenschr. 1953 Jan 3;83(1):4–7. [PubMed]
  • KEECH MK. Human skin collagen from different age groups before and after collagenase digestion; an electron microscopic study. Ann Rheum Dis. 1955 Mar;14(1):19–50. [PMC free article] [PubMed]
  • LYNCH JB, WATT J. Diffuse endomyocardial sclerosis. Br Heart J. 1957 Apr;19(2):173–185. [PMC free article] [PubMed]
  • MACDONALD RA, ROBBINS SL. Pathology of the heart in the carcinoid syndrome; a comparative study. AMA Arch Pathol. 1957 Feb;63(2):103–112. [PubMed]
  • MACDONALD RA, ROBBINS SL, MALLORY GK. Dermal fibrosis following subcutaneous injections of serotonin creatinine sulphate. Proc Soc Exp Biol Med. 1958 Feb;97(2):334–337. [PubMed]
  • MACFARLANE PS, DALGLIESH CE, DUTTON RW, LENNOX B, NYHUS LM, SMITH AN. Endocrine aspects of argentaffinoma, with special reference to the use of urinary 5-hydroxyindoleacetic acid estimations in diagnosis. Scott Med J. 1956 Apr;1(4):148–155. [PubMed]
  • MCKUSICK VA. Carcinoid cardiovascular disease. Bull Johns Hopkins Hosp. 1956 Jan;98(1):13–36. [PubMed]
  • MILLS GY. The syndrome of intestinal carcinoid, pulmonary valvular stenosis and cutaneous flush. Ann Intern Med. 1956 Dec;45(6):1213–1221. [PubMed]
  • PAGE IH. Serotonin (5-hydroxytryptamine); the last four years. Physiol Rev. 1958 Apr;38(2):277–335. [PubMed]
  • PAGE IH, CORCORAN AC, UDENFRIEND S, SZOEDSMA A, WEISSBACH H. Argentaffinoma as endocrine tumour. Lancet. 1955 Jan 22;268(6856):198–199. [PubMed]
  • PEARSON CM, FITZGERALD PJ. Carcinoid tumors; a re-emphasis of their malignant nature; review of 140 cases. Cancer. 1949 Nov;2(6):1005–illust. [PubMed]
  • REID G. Circulatory effects of 5-hydroxytryptamine. J Physiol. 1952 Dec;118(4):435–453. [PubMed]
  • ROWLEY DA, BENDITT EP. 5-Hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats. J Exp Med. 1956 Apr 1;103(4):399–412. [PMC free article] [PubMed]
  • SCHNECKLOTH R, PAGE IH, DEL GRECO F, CORCORAN AC. Effects of serotonin antagonists in normal subjects and patients with carcinoid tumors. Circulation. 1957 Oct;16(4):523–532. [PubMed]
  • SJOERDSMA A, WEISSBACH H, UDENFRIEND S. A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Am J Med. 1956 Apr;20(4):520–532. [PubMed]
  • SNOW PJ, LENNARD-JONES JE, CURZON G, STACEY RS. Humoral effects of metastasising carcinoid tumours. Lancet. 1955 Nov 12;269(6898):1004–1009. [PubMed]
  • THORSON A, BIORCK G, BJORKMAN G, WALDENSTROM J. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome. Am Heart J. 1954 Jun;47(5):795–817. [PubMed]
  • UDENFRIEND S, WEISSBACH H, CLARK CT. The estimation of 5-hydroxytryptamine (serotonin) in biological tissues. J Biol Chem. 1955 Jul;215(1):337–344. [PubMed]
  • WALDENSTROM J. Carcinoidtumörer och vasomotorik; ett påpekande. Sven Lakartidn. 1953 Mar 27;50(13):690–692. [PubMed]
  • WOOD P. An appreciation of mitral stenosis: II. Investigations and results. Br Med J. 1954 May 15;1(4871):1113–1124. [PMC free article] [PubMed]

Articles from British Heart Journal are provided here courtesy of BMJ Group